ACETYLCYSTEINE 2% OPTH SOLN, Rx only, Red Mountain Compounding Rx
First Royal Care Co. LLC
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Prescription and over-the-counter medications
First Royal Care Co. LLC
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
First Royal Care Co. LLC
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
First Royal Care Co. LLC
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Chemical contamination; presence of benzene
Teva Pharmaceuticals USA
Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol
cGMP Deviations
Chemical contamination; presence of benzene
Out of specification result observed in a dissolution test at the 9-month long term stability time point.
Failed Dissolution Specifications: results were above specification.
Chemical contamination; presence of benzene
Labeling: Label Lacks Warning or Rx Legend: Finished product did not include the statement on the flip cap vial, "WARNING: PARALYZING AGENT"
Teva Pharmaceuticals USA
Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol
Chemical contamination; presence of benzene
cGMP Deviations
Teva Pharmaceuticals USA
Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol
cGMP Deviations
Dr. Reddy's Laboratories
CGMP Deviations: Customer complaint for the presence of a staple co-mingled with capsules within the bottle.
Chemical contamination; presence of benzene
Teva Pharmaceuticals USA
Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol
Teva Pharmaceuticals USA
Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol